427 studies found for:    butyrylcholinesterase
Show Display Options
Rank Status Study
1 Completed Study to Investigate the Safety and Tolerability of AZD8848 in Butyrylcholinesterase Deficient Subjects
Condition: Butyrylcholinesterase Deficiency
Intervention: Drug: AZD8848
2 Completed A Study of Plasma-Derived Human Butyrylcholinesterase Administered Intramuscularly
Condition: Healthy
Interventions: Drug: Human butyrylcholinesterase (HuBChE) derived from human plasma;   Drug: Placebo: Normal saline
3 Completed Pharmacokinetic (PK) and Safety Study of Plasma-Derived Human Butyrylcholinesterase Administered Intravenously
Conditions: Chemical Terrorism;   Chemical Warfare
Interventions: Drug: Human Butyrylcholinesterase (HuBChE) derived from human plasma;   Drug: Placebo: Normal saline
4 Completed Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults
Conditions: Mental Health;   Geriatrics
Interventions: Drug: donepezil;   Drug: Placebo (cornstarch)
5 Not yet recruiting Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Rivastigmine
6 Completed Estimation of Functional Liver Reserve Using Cholinesterases
Conditions: Hepatocellular Carcinoma;   Cirrhosis;   Liver Neoplasm;   Liver Disease
Intervention:
7 Completed Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: memantine
8 Completed Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: lecozotan SR (SRA-333)
9 Recruiting Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch
10 Not yet recruiting Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI
Conditions: Traumatic Brain Injury;   Cognitive Impairment
Intervention: Drug: Rivastigmine Transdermal Patch
11 Completed Use of Donepezil for Treatment of Cocaine Dependence
Condition: Cocaine Abuse and Dependence
Intervention: Drug: Donepezil, 5 mg daily
12 Completed To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.
Condition: Alzheimer's Disease
Intervention: Drug: Atorvastatin
13 Completed Effects of Donepezil on Deficits Associated With Age-Related Decrease of Growth Hormone
Condition: Elderly
Intervention: Drug: Donepezil
14 Completed Efficacy of Rivastigmine in Patients With Down Syndrome
Condition: Down Syndrome
Intervention: Drug: Rivastigmine
15 Completed Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia
Conditions: Parkinson's Disease;   Apathy;   no Dementia
Interventions: Drug: rivastigmine;   Drug: placebo
16 Completed Treatment of Tardive Dyskinesia With Galantamine
Condition: Tardive Dyskinesia
Intervention: Drug: Galantamine
17 Unknown  Dementia Early Recognition and Response in Primary Care
Condition: Dementia
Intervention: Other: Educational Dementia training
18 Terminated Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice
Condition: Lice Infestations
Intervention: Drug: MALG
19 Active, not recruiting Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice
Condition: Pediculosis
Intervention: Drug: MALG (malathion) Treatment
20 Recruiting The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy
Condition: Myasthenia Gravis
Interventions: Drug: Azathioprine;   Drug: Leflunomide

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years